首页> 外文期刊>Antimicrobial agents and chemotherapy. >Assessment of serum (1->3)-beta-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosis.
【24h】

Assessment of serum (1->3)-beta-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosis.

机译:在侵袭性肺曲霉菌病小鼠模型中评估血清(1-> 3)-β-D-葡聚糖的浓度,以衡量疾病负担。

获取原文
获取原文并翻译 | 示例
           

摘要

Serum (1-->3)-beta-D-glucan concentrations were serially measured in the presence and absence of antifungal therapy in a murine model of invasive pulmonary aspergillosis. Serum (1-->3)-beta-D-glucan was detected early during the course of infection, and reductions in this biomarker were associated with improved survival in animals treated with antifungal agents.
机译:在侵袭性肺曲霉菌病的小鼠模型中,在有无真菌治疗的情况下,连续测量血清(1-> 3)-β-D-葡聚糖的浓度。在感染过程中早期发现了血清(1-> 3)-β-D-葡聚糖,这种生物标志物的减少与抗真菌剂治疗的动物的存活率提高有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号